IL148421A0 - Pharmaceutical compositions and methods of using secreted frizzled related protein - Google Patents
Pharmaceutical compositions and methods of using secreted frizzled related proteinInfo
- Publication number
- IL148421A0 IL148421A0 IL14842100A IL14842100A IL148421A0 IL 148421 A0 IL148421 A0 IL 148421A0 IL 14842100 A IL14842100 A IL 14842100A IL 14842100 A IL14842100 A IL 14842100A IL 148421 A0 IL148421 A0 IL 148421A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- pharmaceutical compositions
- related protein
- secreted frizzled
- frizzled related
- Prior art date
Links
- 102100030053 Secreted frizzled-related protein 3 Human genes 0.000 title 1
- 108010020277 WD repeat containing planar cell polarity effector Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39483299A | 1999-09-13 | 1999-09-13 | |
PCT/US2000/025035 WO2001019855A2 (en) | 1999-09-13 | 2000-09-13 | Pharmaceutical compositions and methods of using secreted frizzled related protein |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148421A0 true IL148421A0 (en) | 2002-09-12 |
Family
ID=23560597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14842100A IL148421A0 (en) | 1999-09-13 | 2000-09-13 | Pharmaceutical compositions and methods of using secreted frizzled related protein |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1212355A2 (zh) |
JP (1) | JP2003512304A (zh) |
CN (2) | CN102988957A (zh) |
AU (1) | AU7131200A (zh) |
BR (1) | BR0014183A (zh) |
CA (1) | CA2383360A1 (zh) |
CZ (1) | CZ2002903A3 (zh) |
IL (1) | IL148421A0 (zh) |
MX (1) | MXPA02002624A (zh) |
NZ (1) | NZ529560A (zh) |
WO (1) | WO2001019855A2 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL208368B1 (pl) | 2000-02-29 | 2011-04-29 | Alcon Inc | Sposób diagnozowania jaskry |
US6600018B1 (en) | 2000-04-10 | 2003-07-29 | The United States Of America As Represented By The Department Of Health And Human Services | Secreted frizzled related protein, sFRP, fragments and methods of use thereof |
AU2001280680A1 (en) * | 2000-07-19 | 2002-01-30 | Genzyme Corporation | Phosphatonin-related gene and methods of use thereof |
PT1387854E (pt) | 2001-01-10 | 2012-06-26 | Us Dept Health | Sfrp e motivos de peptídeos que interagem com a sfrp e respectivos métodos de utilização |
EP1222933A1 (en) * | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
WO2002081745A2 (en) * | 2001-04-05 | 2002-10-17 | Proskelia Pharmaceuticals | Genes involved in osteogenesis, and methods of use |
AU2002308557A1 (en) | 2001-05-01 | 2002-11-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
US7713526B2 (en) | 2001-05-01 | 2010-05-11 | The Regents Of The University Of California | Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas |
GB0111004D0 (en) * | 2001-05-04 | 2001-06-27 | Univ Sheffield | Screening method |
US20060281179A1 (en) * | 2001-11-15 | 2006-12-14 | Yoshiki Sasai | Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof |
EP1913952B1 (en) * | 2002-12-05 | 2011-03-09 | The Board Of Trustees Of The University Of Arkansas | Molecular determinants of myeloma bone disease and uses thereof |
EP1616026A1 (en) * | 2003-04-14 | 2006-01-18 | Novartis AG | Gene expression associated with osteoblast differentiation |
CN104726460A (zh) * | 2013-12-22 | 2015-06-24 | 上海交通大学医学院 | 蛋白sFRP-5在治疗银屑病的药物中的应用 |
KR101835939B1 (ko) * | 2014-08-26 | 2018-03-23 | 연세대학교 산학협력단 | Wls 단백질의 특정 모티프를 인지하는 항체 및 이를 포함하는 약제학적 조성물 |
EP3696192A1 (en) * | 2019-02-15 | 2020-08-19 | Consejo Superior De Investigaciones Científicas | Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease |
CN110361541A (zh) * | 2019-07-23 | 2019-10-22 | 上海交通大学医学院附属瑞金医院 | sFRP2和PCPE1作为联合靶点在制备纤维化疾病药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681701A (en) * | 1993-07-12 | 1997-10-28 | Mayo Foundation For Medical Education And Research | Immortalized human fetal osteoblastic cells |
CN1151744A (zh) * | 1994-07-04 | 1997-06-11 | 武田药品工业株式会社 | 膦酸化合物及其制备和应用 |
AU4981797A (en) * | 1996-10-11 | 1998-05-11 | Government Of The United States Of America, The | Isolation and method of using tissue growth-inducing frzb protein |
AU7704498A (en) * | 1997-05-29 | 1998-12-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Human frp and fragments thereof including methods for using them |
-
2000
- 2000-09-13 MX MXPA02002624A patent/MXPA02002624A/es active IP Right Grant
- 2000-09-13 BR BR0014183-6A patent/BR0014183A/pt not_active IP Right Cessation
- 2000-09-13 CN CN200910208473XA patent/CN102988957A/zh active Pending
- 2000-09-13 EP EP00960097A patent/EP1212355A2/en not_active Withdrawn
- 2000-09-13 CZ CZ2002903A patent/CZ2002903A3/cs unknown
- 2000-09-13 NZ NZ529560A patent/NZ529560A/en not_active IP Right Cessation
- 2000-09-13 IL IL14842100A patent/IL148421A0/xx unknown
- 2000-09-13 CA CA002383360A patent/CA2383360A1/en not_active Abandoned
- 2000-09-13 CN CN00815431A patent/CN1387537A/zh active Pending
- 2000-09-13 JP JP2001523632A patent/JP2003512304A/ja active Pending
- 2000-09-13 AU AU71312/00A patent/AU7131200A/en not_active Abandoned
- 2000-09-13 WO PCT/US2000/025035 patent/WO2001019855A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CZ2002903A3 (cs) | 2002-07-17 |
JP2003512304A (ja) | 2003-04-02 |
WO2001019855A2 (en) | 2001-03-22 |
BR0014183A (pt) | 2002-05-14 |
NZ529560A (en) | 2005-05-27 |
EP1212355A2 (en) | 2002-06-12 |
WO2001019855A3 (en) | 2002-01-24 |
CN1387537A (zh) | 2002-12-25 |
AU7131200A (en) | 2001-04-17 |
MXPA02002624A (es) | 2002-07-30 |
CN102988957A (zh) | 2013-03-27 |
CA2383360A1 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20004741D0 (no) | Farmasøytiske blandinger for forlenget peptidfrigjøring og fremstillingsmetode | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
IL148421A0 (en) | Pharmaceutical compositions and methods of using secreted frizzled related protein | |
HUP9902655A3 (en) | Pharmaceutical composition of hedgehog proteins and use thereof | |
EP1181390A4 (en) | 27 HUMAN SECRETED PROTEINS | |
EP1212342A4 (en) | 18 HUMAN-SECRETED PROTEINS | |
EP1175438A4 (en) | 62 HUMANE SECRETIED PROTEINS | |
EP1192278A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1192176A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1165827A4 (en) | 45 HUMAN SECRETED PROTEINS | |
EP1175439A4 (en) | 49 HUMANE SECRETIED PROTEINS | |
EP1159284A4 (en) | 33 HUMAN SECRETARY PROTEINS | |
EP1189917A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1185543A4 (en) | 50 HUMAN-SECRETED PROTEINS | |
PT1005342E (pt) | Composicoes farmaceuticas de tizoxanida e nitazoxanida | |
EP1173477A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1206573A4 (en) | 26 HUMAN SECRETED PROTEINS | |
EP1203005A4 (en) | 25 HUMAN SECRETED PROTEINS | |
EP1144614A4 (en) | HUMAN, ELIMINATED PROTEINS | |
EP1171460A4 (en) | 48 HUMAN SECRETED PROTEINS | |
EP1165602A4 (en) | 49 PROTEINS SECRETED BY A HUMAN BEING | |
EP1169332A4 (en) | 49 HUMAN SECRETED PROTEINS | |
EP1165828A4 (en) | 50 HUMAN SECRETED PROTEINS | |
HUP9900251A3 (en) | Pharmaceutical compositions containing hedgehog proteins and use of former compositions | |
AU2001284651A1 (en) | Secreted proteins and methods of using same |